Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hooper

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Cancer Research|April 19, 2005
Fetal stromal-dependent paracrine and intracrine vascular endothelial growth factor-a/vascular endothelial growth factor receptor-1 signaling promotes proliferation and motility of human primary myeloma cellsLoïc Vincent, David K Jin, Matthias A Karajannis, et al.
Frontiers in Immunology|May 2, 2022
A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid TumorsJames J Harding, Ignacio Garrido-Laguna, Xiaoying Chen, et al.
BMC Genomics|January 4, 2020
Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumorsWenyan Zhong, Jeremy S Myers, Fang Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2008
Generation of a functional and durable vascular niche by the adenoviral E4ORF1 geneMarco Seandel, Jason M Butler, Hideki Kobayashi, et al.
The Journal of Clinical Investigation|December 5, 2006
Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularizationHans-Georg Kopp, Andrea T Hooper, M Johan Broekman, et al.
Open Forum Infectious Diseases|December 19, 2023
Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 InfectionMeng Xu, Meagan P O'Brien, Andrea T Hooper, et al.
Mbio|October 18, 2022
Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing AntibodiesAndrea T Hooper, Selin Somersan-Karakaya, Shane E McCarthy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint InhibitorsChanghua Ji, Marc D Roy, Jonathan Golas, et al.
Cancer Cell|March 14, 2007
In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcomaAgata D'Agostino Mutlu, Lucas E Cavallin, Loïc Vincent, et al.
Australian Veterinary Journal|September 24, 1999
Epidemic of blindness in kangaroos--evidence of a viral aetiologyP T Hooper, R A Lunt, A R Gould, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Cancer Research|April 19, 2005
Fetal stromal-dependent paracrine and intracrine vascular endothelial growth factor-a/vascular endothelial growth factor receptor-1 signaling promotes proliferation and motility of human primary myeloma cellsLoïc Vincent, David K Jin, Matthias A Karajannis, et al.
Frontiers in Immunology|May 2, 2022
A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid TumorsJames J Harding, Ignacio Garrido-Laguna, Xiaoying Chen, et al.
BMC Genomics|January 4, 2020
Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumorsWenyan Zhong, Jeremy S Myers, Fang Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2008
Generation of a functional and durable vascular niche by the adenoviral E4ORF1 geneMarco Seandel, Jason M Butler, Hideki Kobayashi, et al.
The Journal of Clinical Investigation|December 5, 2006
Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularizationHans-Georg Kopp, Andrea T Hooper, M Johan Broekman, et al.
Open Forum Infectious Diseases|December 19, 2023
Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 InfectionMeng Xu, Meagan P O'Brien, Andrea T Hooper, et al.
Mbio|October 18, 2022
Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing AntibodiesAndrea T Hooper, Selin Somersan-Karakaya, Shane E McCarthy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint InhibitorsChanghua Ji, Marc D Roy, Jonathan Golas, et al.
Cancer Cell|March 14, 2007
In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcomaAgata D'Agostino Mutlu, Lucas E Cavallin, Loïc Vincent, et al.
Australian Veterinary Journal|September 24, 1999
Epidemic of blindness in kangaroos--evidence of a viral aetiologyP T Hooper, R A Lunt, A R Gould, et al.
Pageof 17